Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramanathan, R. K.
Right arrow Articles by Belani, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramanathan, R. K.
Right arrow Articles by Belani, C. P.
(Chest. 1996;110:289-292.)
© 1996 American College of Chest Physicians

Pulmonary Infiltrates Following Administration of Paclitaxel

Ramesh K. Ramanathan MD1; Vundyala V. Reddy MD2; J. Michael Holbert MD1; and Chandra P. Belani MD1

1 From the University of Pittsburgh Cancer Institute and the University of Pittsburgh School of Medicine, Pittsburgh
2 From the Medical Oncology P.A., Macon, Ga.

The clinical spectrum of hypersensitivity reactions reported with paclitaxel has not included the occurrence of pulmonary infiltrates. This report describes three patients who developed transient pulmonary infiltrates after receiving paclitaxel. These infiltrates were noted 2 days to 2 weeks after administration of paclitaxel. The infiltrates resolved spontaneously in all the patients but one of them did receive steroid therapy. This syndrome of transient pulmonary infiltrates did not reoccur in the two patients who were rechallenged with paclitaxel. Physicians should be made aware of this unique occurrence during the course of treatment with paclitaxel.

Key Words: carboplatin • hypersensitivity reaction • nonsmall cell lung cancer • paclitaxel • pulmonary infiltrates

Submitted on July 17, 1995
Accepted on February 2, 1996




This article has been cited by other articles:


Home page
 ChestHome page
B. Vahid and P. E. Marik
Pulmonary Complications of Novel Antineoplastic Agents for Solid Tumors
Chest, February 1, 2008; 133(2): 528 - 538.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
R. F. Munden, S. S. Swisher, C. W. Stevens, and D. J. Stewart
Imaging of the Patient with Non-Small Cell Lung Cancer
Radiology, December 1, 2005; 237(3): 803 - 818.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Li, B. Juliar, C. Yiannoutsos, R. Ansari, E. Fox, M. J. Fisch, L. H. Einhorn, and C. J. Sweeney
Weekly Paclitaxel and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study
J. Clin. Oncol., February 20, 2005; 23(6): 1185 - 1191.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
E. Esteban, L. Gonzalez de Sande, Y. Fernandez, N. Corral, J Fra, I. Muniz, J. M. Vieitez, I. Palacio, J. L. Fernandez, E. Estrada, et al.
Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
Ann. Onc., November 1, 2003; 14(11): 1640 - 1647.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. Akira, H. Ishikawa, and S. Yamamoto
Drug-induced Pneumonitis: Thin-Section CT Findings in 60 Patients
Radiology, September 1, 2002; 224(3): 852 - 860.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
P. Wong, A. N. Leung, G. J. Berry, K. A. Atkins, J. G. Montoya, S. J. Ruoss, and F. E. Stockdale
Paclitaxel-Induced Hypersensitivity Pneumonitis: Radiographic and CT Findings
Am. J. Roentgenol., March 1, 2001; 176(3): 718 - 720.
[Full Text] [PDF]

Home page
 RadioGraphicsHome page
S. E. Rossi, J. J. Erasmus, H. P. McAdams, T. A. Sporn, and P. C. Goodman
Pulmonary Drug Toxicity: Radiologic and Pathologic Manifestations
RadioGraphics, September 1, 2000; 20(5): 1245 - 1259.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. J. Moos, D. T. Muskardin, and F. A. Fitzpatrick
Effect of Taxol and Taxotere on Gene Expression in Macrophages: Induction of the Prostaglandin H Synthase-2 Isoenzyme
J. Immunol., January 1, 1999; 162(1): 467 - 473.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Chest Physicians.